Cargando…
Reply: Lecanemab: turning point, or status quo? An ethics perspective
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473552/ https://www.ncbi.nlm.nih.gov/pubmed/36995943 http://dx.doi.org/10.1093/brain/awad102 |
| _version_ | 1785100298970202112 |
|---|---|
| author | Hardy, John Mummery, Catherine |
| author_facet | Hardy, John Mummery, Catherine |
| author_sort | Hardy, John |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10473552 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104735522023-09-02 Reply: Lecanemab: turning point, or status quo? An ethics perspective Hardy, John Mummery, Catherine Brain Letter to the Editor Oxford University Press 2023-03-30 /pmc/articles/PMC10473552/ /pubmed/36995943 http://dx.doi.org/10.1093/brain/awad102 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Hardy, John Mummery, Catherine Reply: Lecanemab: turning point, or status quo? An ethics perspective |
| title | Reply: Lecanemab: turning point, or status quo? An ethics perspective |
| title_full | Reply: Lecanemab: turning point, or status quo? An ethics perspective |
| title_fullStr | Reply: Lecanemab: turning point, or status quo? An ethics perspective |
| title_full_unstemmed | Reply: Lecanemab: turning point, or status quo? An ethics perspective |
| title_short | Reply: Lecanemab: turning point, or status quo? An ethics perspective |
| title_sort | reply: lecanemab: turning point, or status quo? an ethics perspective |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473552/ https://www.ncbi.nlm.nih.gov/pubmed/36995943 http://dx.doi.org/10.1093/brain/awad102 |
| work_keys_str_mv | AT hardyjohn replylecanemabturningpointorstatusquoanethicsperspective AT mummerycatherine replylecanemabturningpointorstatusquoanethicsperspective |